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Abstract
Background: The risk-adjusted mortality rate (RAMR) is used widely by healthcare agencies to evaluate hospital 
performance. The RAMR is insensitive to case volume and requires a confidence interval for proper interpretation, 
which results in a hypothesis testing framework. Unfamiliarity with hypothesis testing can lead to erroneous 
interpretations by the public and other stakeholders. We argue that screening, rather than hypothesis testing, is 
more defensible. We propose an alternative to the RAMR that is based on sound statistical methodology, easier to 
understand and can be used in large-scale screening with no additional data requirements.
Methods: We use an upper-tail probability to screen for hospitals performing poorly and a lower-tail probability 
to screen for hospitals performing well. Confidence intervals and hypothesis tests are not needed to compute or 
interpret our measures. Moreover, unlike the RAMR, our measures are sensitive to the number of cases treated.
Results: To demonstrate our proposed methodology, we obtained data from the New York State Department of 
Health for 10 Inpatient Quality Indicators (IQIs) for the years 2009-2013. We find strong agreement between the 
upper tail probability (UTP) and the RAMR, supporting our contention that the UTP is a viable alternative to the 
RAMR.
Conclusion: We show that our method is simpler to implement than the RAMR and, with no need for a confidence 
interval, it is easier to interpret. Moreover, it will be available for all hospitals and all diseases/conditions regardless 
of patient volume.
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Implications for policy makers
Policy-makers can benefit from the results of our study in the following ways:
• We frame the evaluation of hospitals in terms of screening rather than hypothesis testing.
• Unlike the risk-adjusted mortality rate (RAMR) , our method can be applied to all situations, regardless of the number of cases, thereby providing 
a more comprehensive evaluation of each hospital.
• Our alternative measure has a clear and practical interpretation.
Implications for the public
In choosing a hospital for treatment of a serious disease or condition, you will want to consider many factors, perhaps the most important being your 
likelihood of surviving the hospitalization. You may find the risk-adjusted mortality rate (RAMR) difficult to interpret since that will require that you 
have a benchmark value for comparison and an understanding of confidence intervals. Our proposed method will provide you with a measure that:
• has a clear and practical interpretation,
• does not rely on a benchmark or an understanding of confidence intervals, and
• is available regardless of the number of cases were treated by the hospital last year.
Therefore, you will be sure to have information on all hospitals under consideration, and that the information will be readily understood without 
confusion.
Key Messages 
Background 
Healthcare costs in the United States rose 5.3% in 2014 to 
$3.0 trillion, or over $9500 per capita, reaching 17.5% of 
gross domestic product (GDP),1 which has created recurring 
and urgent demands to reduce healthcare costs. Hospitals 
may look for ways to reduce cost by reducing the number of 
treatments, using less expensive interventions, or reducing 
length of stay, thereby risking quality degradation. Thus, the 
need to monitor provider performance has perhaps never 
been greater.
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Comparing hospitals based on their outcome measures is a 
relatively common practice. Healthcare agencies often use 
hospital mortality rates within specific disease or condition 
categories to measure performance. Often state health 
departments and the Center for Medicare and Medicaid2 
release these reports to the public. The Leapfrog Group3 and 
the Agency for Healthcare Research and Quality (AHRQ)4 
contribute to these reports. The public as well as healthcare 
agencies look to these reports, which may be difficult to 
interpret, to find quality healthcare providers.
A proper comparison of mortality rates must include an 
adjustment for risk variation that “levels the playing field” so 
that a hospital’s evaluation is independent of the risk profile of 
its patients. Risk factors commonly include age, comorbidities, 
illness severity, and other patient and case characteristics. The 
most commonly used adjustment method is the risk-adjusted 
mortality rate (RAMR) defined later.
Hibbard et al5 found that hospitals whose RAMRs were made 
public were more likely to engage in quality improvements 
efforts than those who had a confidential quality report 
or no quality report at all. Baker6 showed that the 30-day 
mortality rate in New York State (NYS) after coronary artery 
bypass graft declined 41% between 1989 and 1992 after 
public reporting, and that published mortality rates impacted 
referral rates among cardiologists in NYS, thereby affecting 
provider market share and patient choice of healthcare 
provider. Schneider and Lieberman7 report that, when 
choosing health plans, employers use these “report cards” 
to identify high quality health plans at reasonable costs. 
Similarly, employees may select plans, doctors and hospitals 
using report card information about providers, quality score, 
price and accessibility. Moreover, a poorly rated provider may 
cease operations leaving the local area with a diminished 
supply of a critical healthcare service.
However, previous studies have questioned the use of the 
RAMR for this adjustment. Iezzoni8 shows that different 
methods can provide varying judgments. Thomas and Hofer9 
questioned the accuracy of the RAMR as a valid indicator of 
a hospital’s quality performance, and conclude that “reports 
that measure quality using RAMRs misinform the public 
about hospital performance.” Dimick et al10 show that the 
RAMR may not be appropriate for all procedures, particularly 
when the sample size is small. Scott11 discusses the statistical 
difficulties associated with a rare outcome (death), the 
omission or difficulty of proper measurement of patient-
related prognostic factors, and the weak and inconsistent 
correlation between hospital-wide RAMR and explicit quality 
indicators. He concludes the RAMR is a poor indicator of 
unsafe hospital care.
There are a number of ways a hospital’s performance is 
measured. Racz and Sedransk12 modeled risk-adjusted 
assessments utilizing Bayesian and frequentist indirect 
standardization methods, which they compared to the RAMR 
for “provider profiling.” These methodologies produced very 
similar results although they found markedly fewer outlying 
hospitals when the random-effects assumption was applied 
to the hospitals. The Leapfrog Group3 provides a hospital 
safety score that is generally a grading system that shows 
how safe a hospital is for patients. The purpose of the score 
is to provide a mechanism to consumers in which they can 
educate themselves about the safety of a facility they may 
be considering. The scores are publically reported and are 
available online. In addition, the Joint Commission’s ORYX 
program13 integrates performance measurement into their 
accreditation and quality improvement processes. The Center 
for Medicare and Medicaid Services (CMS)2 publicly reports 
process performance measures based on data collected by the 
Hospital Quality Alliance (HQA).14
In this paper, we will demonstrate that the RAMR is 
intrinsically a highly flawed performance measure and that, 
moreover, it is applied improperly. We will then propose an 
alternative to the RAMR, along with statistically appropriate 
implementation methods, that avoids all the problems listed 
above without requiring additional data. Our alternative 
measure has a clear and practical interpretation, is based 
on standard statistical theory and methods and, unlike the 
RAMR, can be applied regardless of the number of cases.
Methods
We demonstrate our methodology using data from the NYS 
Department of Health (NYS DOH).15 We chose to test our 
model using NYS data for several reasons. NYS was among the 
first states to use the RAMR, applying it to cardiac surgeons 
and the hospitals in which they performed cardiac surgery 
starting in 1989. Kasprak16 cites the NYS DOH program 
as “the first program in the country to produce public data 
on outcomes for cardiac surgery and is the nation’s longest 
running program of its kind.” During the intervening 28 years, 
the NYS DOH has dramatically expanded its use of the RAMR 
to 24 inpatient quality indicators (IQIs). It also applies the 
methodology to complications and readmissions. NYS DOH 
makes its raw data readily available to the public through its 
web site.15 We believe that, if we can effect improvements in 
NYS, then other states are likely to follow.
The Risk-Adjusted Mortality Rate
The RAMR attempts to account for the differing risk profiles 
of patients. It is standard practice to use a logistic regression 
model for a given procedure or illness to estimate each 
patient’s probability of death based on their patient and case 
characteristics. The mean and standard deviation of the 
number of deaths, and therefore the expected mortality rate 
(EMR) for a procedure or illness at a given hospital, is then 
estimated from these probabilities. The ratio of the observed 
mortality rate (OMR), which equals the number of deaths 
divided by the number of cases, to the EMR is then multiplied 
by the statewide observed mortality rate (SOMR) or national 
mortality rate (NMR) to obtain the RAMR.
Suppose that a hospital treats n patients with a particular 
diagnosis and that X of these patients die. Then the OMR 
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= X/n. Define a variable called Death, which equals 1 if the 
patient died, or equals to 0 if the patient survived. Next, 
consider a logistic regression model that has Death as its 
dependent variable and a set of established mortality risk 
factors for that diagnosis as its independent variables. Suppose 
that this model estimates probabilities of death of p1, p2, …, 
pn, for the n patients. Then the hospital’s EMR= 1
1 n
ii
p
n =∑  and 
its OMRRAMP SOMR
EMR
 =  
 
. Thus, RAMR < SOMR (alternatively, 
RAMR > SOMR) indicates better-than-expected (or worse-
than-expected) performance.
According to Marang-van de Mheen and Shojania17 the 
hospital standardized mortality ratio ( OMRHSMR
EMR
= ) is not a 
sufficient measure to inform patients and policy-makers as to 
whether the mortality risk is higher in a hospital compared to 
another. In addition, the HSMR may be affected by Simpson’s 
paradox. Although this may not cause direct harm to a patient, 
this may cause hospitals that need to address problems not to 
do so and may cause hospitals that actually do have problems 
not to address them.
Shortcomings of the Risk-Adjusted Mortality Rate and its 
Application
We identify five shortcomings of the RAMR:
The RAMR is a poor indicator of hospital performance: We 
demonstrate that the RAMR needs to be augmented by 
additional information before a proper interpretation of 
its value is possible. Consider Ellenville Regional Hospital, 
located in New York State’s Hudson Valley. In 2013, they 
treated 42 patients with pneumonia, two of whom died. 
Therefore, their OMR was 2/42 = 4.76%. Based on the patient 
and case characteristics of their 42 patients, their EMR was 
2.06%. Thus, their ratio OMR/EMR = 2.31; their OMR was 
2.31 times their EMR. Given that the SOMR for pneumonia 
in 2013 in NYS was 4.60%, the RAMR for Ellenville Regional 
Hospital for pneumonia in 2013 was 2.31 * 4.60% = 10.65%.
Without further analysis, it is easy to interpret this hospital’s 
performance in pneumonia in 2013 as very poor. Based on 
its RAMR, if this hospital treated every pneumonia patient 
in NYS in 2013, then 10.65% of them would have died, not 
4.60%; there would have been 2.31 times as many pneumonia 
deaths.
The NYS DOH15 computes a 95% CI for every RAMR, and 
in this case the interval is (1.29%, 38.45%). This is a very 
wide confidence interval primarily because the sample size is 
small. Also, since the CI for the RAMR contains the SOMR 
(4.60%), the NYS DOH reports that the difference between 
Ellenville Regional Hospital’s RAMR and the SOMR was not 
statistically significant.
Given that this information is made public, and given 
the public’s general lack of understanding of the proper 
interpretation of confidence intervals and statistical 
significance, Ellenville Regional Hospital runs the very real 
risk that people, including the media, will focus only on the 
RAMR since it is the performance measure that the State uses. 
The mysterious confidence interval and the reference to “not 
statistically significant” is likely to be ignored.
The interpretation of the RAMR is obscure: The NYS DOH 
web site that provides the data to the public includes the 
formula given above for computing the RAMR but we 
could find no explanation regarding its interpretation. One 
interpretation is that, if every patient in NYS with the given 
condition had been treated at the given hospital, then the 
RAMR represents the estimated proportion that would have 
died. We seriously doubt that many people would have come 
to this interpretation without guidance.
Moreover, even if they had, it is unlikely that they would 
have recognized the amount of sampling error in the RAMR, 
especially when the sample size is small. We can only wonder 
how many pneumonia (and other) patients might have 
boycotted Ellenville Regional Hospital because of its high 
RAMR, even though it was not statistically significantly 
different from the statewide rate.
The normal distribution is not statistically justified in many 
cases: The computations performed for NYS DOH by The 
Leapfrog Group3 analyze only situations in which the number 
of cases equals 30 or more. They state “This minimum 
reporting requirement was identified from the literature, 
which suggests that 30 cases is generally the point at which 
a non-normal distribution begins to approximate a normal 
distribution, which is important given the Safety Score’s 
use of z-scores for standardizing data across disparate data 
sets.”3
This is a misuse of the normal approximation. The rule cited 
refers to using the normal approximation to the sampling 
distribution of the mean. A mortality rate is a proportion, 
not a mean. The commonly used rule for using the normal 
approximation to the sampling distribution of the proportion 
is that both nπ ≥ 10 and n(1-π) ≥ 10, where π is the hospital’s 
EMR. For pneumonia in 2013, these requirements were not 
met in 110 of the 181 hospitals (60.8%) of the hospitals with 
30 or more cases.
CIs are often misunderstood: The importance of avoiding 
confidence intervals should not be minimized. Several authors 
including Hoekstra et al,18 Belia et al,19 Gigerenzer,20 and 
Lecoutre et al21 have demonstrated the widespread inability of 
undergraduate and master’s degree students, researchers, and 
even statisticians to properly interpret confidence intervals 
and the associated null hypothesis significance tests. More 
relevant to the current application, Wulff et al22 showed the 
difficulty that physicians have in properly interpreting a 
wide range of statistical results, and Scheutz et al23 replicated 
those results for dentists. Given that professionals who use 
statistical inference regularly have problems with the proper 
interpretation of confidence intervals, we question the wisdom 
of using confidence intervals in a context in which the public is 
expected to use them in making critical healthcare decisions. 
Clearly the difficulty in the interpretation of statistical methods 
makes the interpretation of the quality reports confusing. 
In addition, Porter et al24 states “sensitivity to physicians’ 
concerns about being judged unfairly results in a tendency 
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to exclude patients from outcomes comparisons instead of 
incorporating accepted risk-adjustment methods.” 
There is no adjustment for multiple comparisons: NYS 
constructs confidence intervals for each RAMR and uses them 
to test the null hypothesis that the hospital’s performance does 
not differ from the statewide performance. We believe that the 
state should instead view this exercise as a screening process, 
not as a hypothesis testing process. There are two reasons why 
we advocate screening rather than hypothesis testing.
First, the state examines hundreds, if not thousands, of 
such analyses each year (many conditions across nearly 200 
hospitals). This means that the state would need to use a 
multiple comparisons procedure, such as Bonferroni25 or 
Benjamini and Hochberg,26 which would be unlikely to serve 
the desired purposes in these circumstances. Second, there is 
no a priori theoretical reason to believe that any given hospital 
is either better or worse than average.
Proposed Alternative to the Risk-Adjusted Mortality Rate
Our methodology uses two measures: the upper tail 
probability (UTP) to screen for hospitals performing poorly 
and the lower tail probability (LTP) to screen for hospitals 
performing well. Let n be the number of patients treated, d be 
the number of observed deaths, and π be the EMR. Then the 
UTP = P(X ≥ d | n, π) and the LTP = P(X ≤ d | n, π). It should 
be noted that both the UTP and the LTP include the number 
of deaths, d, so they do not sum to one.
The UTP computes the probability that the hospital would 
have had as many deaths as they did, or more, given their 
number of cases and their EMR. A small UTP indicates that 
the hospital’s number of deaths is unusually high. The LTP 
computes the probability that the hospital would have had as 
few deaths as they did, or fewer, given their number of cases 
and their EMR. A small LTP indicates that the hospital’s 
number of deaths is unusually low. Therefore, with either 
the UTP or the LTP, a small value represents either unusually 
poor performance or unusually good performance.
Hamm27 drew on the work of four previous studies to 
construct the list of verbal interpretations of probabilities 
shown in Table 1. For screening purposes, a UTP or an LTP 
less than 5% or 10% might be considered “very unlikely” 
or “rare” and therefore subject to further investigation. The 
choice, of course, depends on the decision-maker.
We approximate the UTP and the LTP using the binomial 
distribution function. We recognize that the use of the 
binomial distribution in this application technically requires 
that each patient in each hospital with a given condition must 
have the same probability of death, which is not the case 
since patients are known to have different patient and case 
characteristics. The calculation of the exact values of the UTP 
and the LTP would require the individual patient probabilities 
of death, which are not publicly available. If they were, the 
resulting probability distribution would be the so-called 
Poisson binomial distribution.
Under the Poisson binomial distribution, the expected 
number of deaths would equal the expected number under 
the traditional binomial distribution but the variance of 
the number of deaths would be smaller. Thus, the tail 
areas computed using the binomial are larger than those 
computed using the Poisson binomial (see Hoeffding28 and 
Boland29). Thus, the UTP and LTP values reported herein 
are conservatively large in the sense that any UTP or LTP 
that we report is greater than the values computed using the 
individual patient probabilities of death.
To illustrate the appropriateness of using the binomial 
distribution as an approximation when computing the UTP 
and LTP, we conducted a simple simulation with 100 patients. 
Suppose that the probabilities of death of the 100 patients, 
p1, p2, …, p100, are uniformly distributed between 0.01 and 
0.09. We simulated the 100 probabilities of death and then 
simulated whether each patient lived or died to obtain the 
simulated total number of deaths. We repeated this process 
1000 times to obtain the estimated probability distribution 
of the total number of deaths. From this distribution, we 
computed the UTP for each possible number of deaths; 
we call these the actual UTPs. Finally, we computed the 
estimated UTPs for each possible number of deaths using the 
binomial distribution with π = 0.05, the mean of the uniform 
distribution between 0.01 and 0.09.
Table 2 shows the actual and estimated UTPs. Figure 1 shows 
the relationship between these values. Clearly, the binomial 
distribution provides a very close approximation. The 
largest positive difference between the actual UTP minus 
the estimated UTP is 0.974–0.963 = 0.011, which occurs at 2 
deaths, while the largest negative difference is 0.370–0.384 = 
−0.014, which occurs at 6 deaths. There is no apparent pattern 
in the differences between the actual and estimated UTPs.
Recall the case of Ellenville Regional Hospital, which, in 2013, 
Table 1. List of Verbal Interpretations of Probabilities, From Table 1 of 
Hamm27
Verbal Expression Value
Absolutely impossible 0.00
Rarely 0.05
Very unlikely 0.10
Seldom 0.15
Not very probable 0.20
Fairly unlikely 0.25
Somewhat unlikely 0.33
Uncertain 0.40
Slightly less than half of the time 0.45
Toss-up 0.50
Slightly more than half the time 0.55
Better than even 0.60
Rather likely 0.70
Good chance 0.75
Quite likely 0.80
Very probable 0.85
Highly probable 0.90
Almost certain 0.95
Absolutely certain 1.00
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had 2 deaths among 42 pneumonia patients whose EMR was 
0.0206. Its RAMR was 10.65, or 2.31 times the SOMR. Recall 
also that it was only after considering the confidence interval 
that we could declare that its RAMR was not statistically 
different from the SOMR.
The UTP in this situation is the binomial probability P(X ≥ 
2 deaths | n = 42, π = 0.0206), which equals 0.214. Thus, there 
is a 21.4% chance that Ellenville Regional Hospital would 
have experienced 2 or more pneumonia deaths given that the 
EMR of its 42 pneumonia patients was 2.06%. This is between 
“Not very probable” and “Fairly unlikely” on Hamm’s scale. 
It is clear that Ellenville Regional Hospital’s performance in 
pneumonia in 2013 did not approach the level of requiring 
greater scrutiny even though its RAMR was 2.31 times the 
SOMR. All that needs to be reported is that its UTP is 21.4% 
and its interpretation is clear: If Ellenville Regional Hospital 
treated 42 pneumonia patients with the same EMR every year, 
then it would experience two or more deaths in 21.4% of the 
years. There is no need for a confidence interval.
Next consider an imaginary Hospital A that treated 420 
pneumonia cases and experienced 20 deaths. Suppose also 
that its EMR was 2.06%. Then its OMR would equal 20/420 = 
4.76%, and its RAMR would be 10.65, all equal to Ellenville’s 
values. However, its UTP would be P(X ≥ 20 deaths | n = 420, 
π = 0.0206) = 0.00057. This is two orders of magnitude below 
“Rarely” and is very close to “Absolutely impossible.”
How often does an event with probability 0.00057 occur? The 
geometric distribution with P = .00057 has an expected value 
of 1/0.00057 = 1754, meaning that, if Hospital A treated 420 
pneumonia patients with the same EMR every year, then it 
would experience 20 or more deaths on average once every 
1754 years. The observed number of deaths at Hospital 
A should therefore be considered highly unusual while 
Ellenville’s is not unusual at all. This demonstrates that the 
Table 2. Simulated UTP Versus Binomial UTP in 1000 Simulation Replications
Deaths Simulated Frequency
Simulated Relative 
Frequency
Binomial 
Probability Simulated UTP Binomial UTP
Simulated UTP − Binomial 
UTP
0 2 0.002 0.006 1.000 1.000 0.000
1 24 0.024 0.031 0.998 0.994 0.004
2 94 0.094 0.081 0.974 0.963 0.011
3 147 0.147 0.140 0.880 0.882 -0.002
4 172 0.172 0.178 0.733 0.742 -0.009
5 191 0.191 0.180 0.561 0.564 -0.003
6 144 0.144 0.150 0.370 0.384 -0.014
7 90 0.090 0.106 0.226 0.234 -0.008
8 70 0.070 0.065 0.136 0.128 0.008
9 38 0.038 0.035 0.066 0.063 0.003
10 13 0.013 0.017 0.028 0.028 0.000
11 8 0.008 0.007 0.015 0.011 0.004
12 7 0.007 0.003 0.007 0.004 0.003
 Abbreviation: UTP, upper tail probability.
 1 
0
1
2
3
4
5
6
7
8
9
10
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0
Bi
no
m
ia
l A
pp
ro
xi
m
at
io
n 
U
TP
Poisson Binomial UTP
Figure 1. Binomial Approximation to the Poisson Binomial UTP for Each Number of Deaths. Abbreviation: UTP, upper tail probability.
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RAMR is insensitive to case volume, which is incorporated 
naturally into the UTP in a statistically sound manner.
Note that the normal approximation is not needed to compute 
the UTP and the LTP. Therefore, we can analyze hospitals 
regardless of the number of cases they treated and their EMRs. 
Thus, by switching to the UTP/LTP methodology, no such 
methodological restrictions exist; NYS could assess situations 
with any number of cases.
Results
We demonstrate our methodology using data from the NYS 
DOH web site.15 The database contains the number of cases 
treated, the number of deaths, and the EMRs for each of 10 
IQIs for the years 2009-2013. The risk adjustments for the 
IQIs studied are explained in the AHRQ quality indicators, 
IQI parameter estimates.24 NYS reports this data only for 
hospitals that had 30 or more cases in the given IQI in the 
given year.
Comparison of the Upper Tail Probability and the Risk-
Adjusted Mortality Rate
We computed the 5-year overall RAMR and UTP across 
all IQIs for 196 hospitals. The Spearman rank correlation 
is −0.8559 (P < .00005), demonstrating strong agreement 
between the two measures. This supports our contention that 
the UTP is a viable alternative to the RAMR.
The RAMR is Not Currently Applied When the Number of 
Cases is Less Than 30
For any situation with fewer than 30 cases, NYS does not 
report the number of cases, the number of deaths, or the 
EMR. However, the State does report the statewide total for 
cases and deaths, which allows us to compute the numbers 
of cases and deaths for situations with less than 30 cases 
taken collectively. In Table 3, we show that the unadjusted 
odds ratios of mortality for patients treated in hospitals that 
perform fewer than 30 cases per year ranges between 1.37 and 
3.71 relative to patients treated in hospitals that perform more 
than 30 cases per year.
It is possible that the adjustment for EMR, for which the data 
are unavailable, would explain this difference. This might 
happen if those situations involving fewer than 30 cases also 
had higher EMRs relative to patients treated in situations 
involving 30 or more cases. To check this possibility, we fit 
a linear regression model using EMR (computed for each 
hospital across all IQIs and all years) as the dependent 
variable and the number of cases (over all IQIs and years) as 
the independent variable. The resulting model, with n = 196 
hospitals, yields a highly statistically significant positive slope 
(P < .00005) suggesting that hospitals with fewer than 30 cases 
in an IQI are unlikely to have patients that are, on average, at 
higher risk of dying.
While it is true that only 2.2% of the cases in the 10 IQIs were 
Table 3. Odds Ratio of Death in Each of 10 IQIs for Hospitals With Fewer Than 30 Cases Versus Hospitals With 30 or More Cases
IQI Code IQI Value Volume Cases Deaths OMR (%) Odds Odds Ratio % Cases % Deaths
IQI08 Esophageal resection mortality rate <30 189 7 3.70 0.0385 1.625 52.2 63.6
≥30 173 4 2.31 0.0237 47.8 36.4
IQI09 Pancreatic resection mortality rate <30 316 17 5.38 0.0569 3.582 23.6 51.5
≥30 1024 16 1.56 0.0159 76.4 48.5
IQI11 AAA repair mortality rate <30 713 42 5.89 0.0626 1.834 31.6 45.2
≥30 1545 51 3.30 0.0341 68.4 54.8
IQI13 Craniotomy mortality rate <30 571 85 14.89 0.1749 3.708 5.9 17.1
≥30 9168 413 4.50 0.0472 94.1 82.9
IQI15 AMI mortality rate <30 742 86 11.59 0.1311 1.944 2.5 4.5
≥30 28 945 1829 6.32 0.0675 97.5 95.5
IQI16 Heart failure mortality rate <30 211 16 7.58 0.0821 1.867 0.4 0.6
≥30 58 635 2469 4.21 0.0440 99.6 99.4
IQI18 Gastrointestinal hemorrhage mortality rate <30 251 14 5.58 0.0591 2.048 0.8 1.6
≥30 30 821 864 2.80 0.0288 99.2 98.4
IQI19 Hip fracture mortality rate <30 625 24 3.84 0.0399 1.374 4.4 5.9
≥30 13 559 383 2.82 0.0291 95.6 94.1
IQI20 Pneumonia mortality rate <30 151 12 7.95 0.0863 1.792 0.3 0.6
≥30 45 387 2086 4.60 0.0482 99.7 99.4
IQI31 Carotid endarterectomy mortality rate <30 564 3 0.53 0.0053 1.505 13.3 18.8
≥30 3671 13 0.35 0.0036 86.7 81.3
Combined <30 4333 306 7.06 0.0760 1.728 2.2 3.6
≥30 192 928 8128 4.21 0.0440 97.8 96.4
Abbreviations: UTP, upper tail probability; AAA, abdominal aortic aneurysm; AMI, acute myocardial infarction; IQI, inpatient quality indicator; OMR, observed 
mortality rate.
Pitocco and Sexton
International Journal of Health Policy and Management, 2018, 7(4), 308–316314
treated in settings with fewer than 30 cases, in some IQIs, the 
percentage is much higher: 52.2% for esophageal resection, 
31.6% for abdominal aortic aneurysm (AAA) repair, 23.6% for 
pancreatic resection and 13.3% for carotid endarterectomy.
The State does not evaluate these situations, apparently due 
to its reliance on the normal approximation to the binomial 
for the purpose of computing a confidence interval for the 
RAMR. By switching to the UTP/LTP methodology, no 
such methodological restrictions exist; the State could assess 
situations with any number of cases.
Screening Rather Than Classification
The UTP and the LTP are not to be confused with upper-tail 
and lower-tail P values commonly used in hypothesis testing. 
There are no hypotheses here to test. We do not, for example, 
create a null hypothesis that the hospital’s mortality rate is 
greater (less) than or equal to its EMR and then use the UTP 
(LTP) to reject or not reject this null hypothesis. To do so 
would require solution of the massive multiple comparisons 
problem25,26 resulting from the very large number of hypothesis 
tests being performed across all hospitals, all diseases and 
conditions, and all years. Rather, the purpose of the analysis 
is to screen for circumstances in which there may have been 
more (fewer) deaths than might be expected based on their 
number of cases and EMR.
Rather than classify a hospital’s performance as average, below 
average, or above average, which would imply a hypothesis 
testing framework, we propose using the UTP as a screening 
measure to identify situations in which there are likely to be 
opportunities for improvement. For example, Table 4 shows 
the performance of Hospital M. While Hospital M did very 
well overall and in three of the nine IQIs, its UTP in one IQI 
(heart failure mortality rate) is small (0.049). It is instructive 
to examine Hospital M’s UTP for the same IQI over the four 
previous years, as shown in Figure 2. It is clear that Hospital 
M’s mortality rate performance with respect to heart failure 
mortality rate has been low for at least 5 years.
Discussion
In this paper, we make two essential points. First, measuring 
hospital performance is essential for quality improvement 
but hypothesis testing is not the appropriate approach. 
Rather, agencies should take a screening approach that seeks 
to identify both where attention may be needed to improve 
performance, and where superior performance is occurring 
that might be emulated elsewhere. Second, the current RAMR 
Table 4. UTPs and LTPs for Hospital M for all IQIs Combined and Individually in 2013
IQI UTP LTP Cases Deaths OMR (%) EMR (%)
All IQIs Combined 0.995 0.007 3722 95 2.55 3.26
AAA repair mortality rate 1.000 0.048 107 0 0.00 2.80
AMI mortality rate 1.000 0.000 655 14 2.14 4.98
Carotid endarterectomy mortality rate 1.000 0.837 66 0 0.00 0.27
Craniotomy mortality rate 0.999 0.002 435 10 2.30 5.17
Gastrointestinal hemorrhage mortality rate 0.622 0.508 462 9 1.95 2.08
Heart failure mortality rate 0.049 0.967 1034 37 3.58 2.67
Hip fracture mortality rate 0.248 0.878 134 5 3.73 2.51
Hip replacement mortality rate 0.301 0.949 237 1 0.42 0.15
Pancreatic resection mortality rate 0.920 0.285 74 1 1.35 3.36
Pneumonia mortality rate 0.680 0.408 518 18 3.47 3.80
Abbreviations: UTP, upper tail probability; AAA, abdominal aortic aneurysm; AMI, acute myocardial infarction; IQI, inpatient quality indicator; OMR, observed 
mortality rate; EMR, expected mortality rate; UTP, upper tail probability; LTP, lower tail probability.
 1 
Figure 2. The UTPs for Heart Failure Mortality Rate in Hospital M Between 2009 and 2013. Abbreviation: UTP, upper tail probability.
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methodology should be replaced. Our proposed alternative 
method, using the UTP and the LTP, should be considered as 
a replacement.
Briefly, we have shown that:
1.	 The RAMR does not provide the information necessary to 
determine whether a hospital’s performance is especially 
bad or especially good, in part because it is insensitive to 
sample size;
2.	 The interpretation of the RAMR is obscure to many 
people;
3.	 The use of the normal distribution to construct a 
confidence interval for the RAMR is not statistically 
justified in many cases;
4.	 While a proper confidence interval for the RAMR can be 
constructed without reference to the normal distribution, 
there is considerable evidence that large portions of 
the population, including physicians, other healthcare 
professionals, and the public, do not have a sufficiently 
fundamental understanding of confidence intervals to 
use them as a basis for healthcare decision-making; and
5.	 The RAMR and its confidence interval are portrayed as if a 
two-tailed hypothesis test were being performed without 
any attempt to adjust for the multiple comparisons that 
are being made.
The current implementation of the RAMR in NYS does not 
examine situations in which a hospital has treated fewer than 
30 cases in a given IQI. We have found that such situations 
may account for as much as half of all such cases statewide. 
This failure is particularly troubling in light of the suggestive 
evidence that higher volume providers tend to perform better. 
This shortcoming disappears when using the UTP/LTP 
approach.
For the purposes of our study, we were unable to apply our 
methodology to situations with fewer than 30 cases since NYS 
DOH does not publish the necessary data. However, there 
is no reason to suspect that there would be any problems 
computing the UTP since the binomial distribution is readily 
available for any number of trials.
Our planned future research involves comparing the UTP/
LTP results with the quality report cards prepared for each 
hospital. To the degree to which they agree, we will know 
that the UTP/LTP and the report cards are sensing similar 
phenomena. To the extent that they disagree, we will have 
an opportunity to learn more about the hospital’s quality 
performance.
In summary, our proposed method is simpler to implement 
than the RAMR – no need for a confidence interval – and it is 
easy to interpret. It is statistically sound and is applicable to all 
situations regardless of the number of cases treated, therefore 
providing a more comprehensive assessment of performance.
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